Alembic Pharmaceuticals informs about press release

08 Mar 2023 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Prazosin Hydrochloride Capsules USP, 1 mg, 2 mg, and 5 mg. In this regard, the company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

668.20 -7.55 (-1.12%)
19-Mar-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1762.65
Dr. Reddys Lab 1271.40
Cipla 1246.95
Zydus Lifesciences 886.35
Lupin 2275.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×